VNDA
Vanda Pharmaceuticals Inc.
$5.24
Earnings Summary
Revenue | $45.27Mn |
Net Profits | $-2.4Mn |
Net Profit Margins | -5.3% |
Highlights
Vanda Pharmaceuticals Inc.’s revenue fell -29.79% since last year same period to $45.27Mn in the Q4 2023. On a quarterly growth basis, Vanda Pharmaceuticals Inc. has generated 16.63% jump in its revenue since last 3-months.
Vanda Pharmaceuticals Inc.’s net profit fell -134.98% since last year same period to $-2.4Mn in the Q4 2023. On a quarterly growth basis, Vanda Pharmaceuticals Inc. has generated -1851.82% fall in its net profits since last 3-months.
Vanda Pharmaceuticals Inc.’s net profit margin fell -149.82% since last year same period to -5.3% in the Q4 2023. On a quarterly growth basis, Vanda Pharmaceuticals Inc. has generated -1602% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Vanda Pharmaceuticals Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 0.05 |
EPS Estimate Current Year | 0.05 |
Highlights
Vanda Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a 155.56% jump from last quarter’s estimates.
Vanda Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.05.
Key Ratios
Key ratios of the Vanda Pharmaceuticals Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.04 |
Highlights
Vanda Pharmaceuticals Inc.’s earning per share (EPS) fell -133.33% since last year same period to -0.04 in the Q4 2023. This indicates that the Vanda Pharmaceuticals Inc. has generated -133.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-07-28 | -0.13 | 0.03 | 123.08% |
2023-11-09 | -0.04 | 0 | 106% |
2024-02-08 | -0.09 | -0.04 | 55.56% |
₹0 US Stocks a/c Opening Fee